Position history for ROYCE & ASSOCIATES LP's holdings in HAEMONETICS CORP MASS
ROYCE & ASSOCIATES LP holds 71,475 shares of HAE (HAEMONETICS CORP MASS), worth $4M as of 2026-Q1. HAE represents 0.0% of ROYCE & ASSOCIATES LP's portfolio.
Current Value
$4M
Current Shares
71,475
Total Value Change
-$93.6M
Total Shares Change
-1.1M
Other major holders of HAE: Capital Research Global Investors
Unchanged |
| 71,475 |
0.0% |
| $4M |
| 0.0% |
| $65.63 |
0 |
| 2025-Q4 | Decreased | 71,475 | -89.8% | $5.7M | 0.1% | $80.98 | 0 |
| 2025-Q3 | Decreased | 701,242 | -44.8% | $34.2M | 0.3% | $48.12 | 0 |
| 2025-Q2 | Increased | 1.3M | +9.4% | $94.8M | 1.0% | $73.80 | 46 |
| 2025-Q1 | Increased | 1.2M | +0.7% | $73.8M | 0.8% | $63.19 | 42 |
| 2024-Q4 | Decreased | 1.2M | -4.7% | $90M | 0.8% | $76.60 | 0 |
| 2024-Q3 | Increased | 1.2M | +2.6% | $97.3M | 0.9% | $79.80 | 43 |
| 2024-Q2 | Decreased | 1.2M | -6.9% | $97.6M | 0.9% | $82.73 | 0 |